Device Trial Radar · NCT02812966
Lutonix or Inpact for tHE tReatment Of fEmeropopliteal Stenosis - Drug Coated Balloon
Last checked: Nov 20, 2026Latest source record: Oct 8, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
35
Actual
Start
Apr 2016
Primary completion
Dec 2, 2019
Study completion Dec 2, 2019
Sponsor
- Lead sponsor
- Wake Forest University Health SciencesAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jun 24, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Investigators hypothesize in patients presenting with significant peripheral arterial disease with clinical indications for treatment with angioplasty, there will be a difference in 12 month patency between the subjects with Lutonix 035 Drug coated Balloon Percutaneous Transluminal Angioplasty Catheter and IN.PACT Admiral Paclitaxel-Coated Percutaneous Transluminal Angioplasty Balloon Catheter.
Conditions
- Peripheral Arterial Disease
Interventions
LutonixDevice
Drug Coated Balloons
IN.PACTDevice
Drug Coated Balloons
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Patency (Peak Systolic Velocity Ratio<=2.4)Time frame: 12 months
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Advocate Illinois Masonic Medical Center
Chicago, Illinois
Advocate Good Samaritan Hospital
Downers Grove, Illinois
Advocate South Suburban Hospital
Hazel Crest, Illinois
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.